- Trials with a EudraCT protocol (280)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (446)
280 result(s) found for: Wing.
Displaying page 1 of 14.
EudraCT Number: 2010-023122-21 | Sponsor Protocol Number: PB002 | Start Date*: 2011-11-08 | ||||||||||||||||
Sponsor Name:King's College London [...] | ||||||||||||||||||
Full Title: Pro-Bono 2- A prospective study of loss of bone mineral density in patients with HIV over time: implications for clinical practice and therapeutic options: Vitamin D sub study. | ||||||||||||||||||
Medical condition: HIV | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-023625-38 | Sponsor Protocol Number: JF003 | Start Date*: 2012-11-13 | |||||||||||
Sponsor Name:Guy's and St Thomas' NHS Foundation Trust | |||||||||||||
Full Title: Investigating the effect of Maraviroc on microbial translocation in HIV-1 infected individuals who are receiving antiretroviral therapy | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000549-21 | Sponsor Protocol Number: MAGSTAR | Start Date*: 2015-03-16 |
Sponsor Name:King's College London [...] | ||
Full Title: MAGnetic versus STAndard technique for sentinel node biopsy in breast cancer compared in a Randomised controlled trial | ||
Medical condition: Many women with breast cancer undergo sentinel lymph node biopsy in order to identify if the breast cancer has spread (metastasis) to the lymph nodes. This study is aimed at evaluating a new magnet... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-019656-41 | Sponsor Protocol Number: ZA/CP/0210 | Start Date*: 2011-08-24 | |||||||||||
Sponsor Name:King’s College London [...] | |||||||||||||
Full Title: Effects of Zoledronic Acid on arterial calcification and arterial stiffness in women – a co-twin randomised double blind, placebo-controlled parallel group, clinical trial | |||||||||||||
Medical condition: Arterial stiffness and arterial calcification | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003025-18 | Sponsor Protocol Number: VAPER | Start Date*: 2015-05-08 |
Sponsor Name:King's College London [...] | ||
Full Title: In Vivo Generation of Optimal Tumour Antigen-specific Anticancer Immune Responses, by Vaccination with Human Telomerase Reverse Transcriptase (hTERT) Peptides, in Combination with Specific Adjuvant... | ||
Medical condition: Advanced malignancies | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005432-32 | Sponsor Protocol Number: 08.0113 | Start Date*: 2009-06-02 | |||||||||||
Sponsor Name:St. George's University of London (SGUL) | |||||||||||||
Full Title: Effects of an Angiotensin Receptor Antagonist Candesartan versus a calcium channel blocker Amlodipine on Microvascular Rarefaction, Endothelial Dysfunction and Microalbuminuria in Essential Hyperte... | |||||||||||||
Medical condition: Essential hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002899-34 | Sponsor Protocol Number: V 5 Protocol | Start Date*: 2007-09-18 |
Sponsor Name:Newcastle Upon tyne Hospitals NHS Foundation Trust | ||
Full Title: Pilot Controlled Clinical Trial of Salvia Officinalis (Sage) for cognitive impairments in Parkinson's Disease | ||
Medical condition: Cognitive impairment in Parkinson's Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-009154-25 | Sponsor Protocol Number: omalizumab/2009/01 | Start Date*: 2009-07-07 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: The effect of a humanised monoclonal anti-IgE antibody (omalizumab) on disease control and bronchial mucosal inflammation in non-atopic (“intrinsic”) asthma | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000395-32 | Sponsor Protocol Number: 2006001 | Start Date*: 2006-03-29 |
Sponsor Name:King's College London | ||
Full Title: The effect of COX-2 Inhibition on Reducing Central Sensitisation of Pain in Osteoarthritis | ||
Medical condition: Osteoarthritis of the knee | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004478-41 | Sponsor Protocol Number: LCC001 | Start Date*: 2015-03-10 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Phase III trial in IntrahepaTic CHolestasis of pregnancy (ICP) to Evaluate urSodeoxycholic acid (UDCA) in improving perinatal outcomes | |||||||||||||
Medical condition: Intrahepatic Cholestasis of pregnancy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002330-38 | Sponsor Protocol Number: RituxiCAN-C4 | Start Date*: 2006-11-22 | |||||||||||
Sponsor Name:King's College London | |||||||||||||
Full Title: Randomised Trial of Anti-CD20 in C4d+ Chronic Allograft Nephropathy | |||||||||||||
Medical condition: Renal Transplant Rejection - chronic | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005091-13 | Sponsor Protocol Number: SMS | Start Date*: 2008-03-06 | |||||||||||
Sponsor Name:Guy's & St Thomas' NHS Foundation Trust [...] | |||||||||||||
Full Title: Phase II study of sorafenib in malignant mesothelioma previously treated with platinum-based chemotherapy | |||||||||||||
Medical condition: Malignant Mesothelioma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003803-39 | Sponsor Protocol Number: 11.0126 | Start Date*: 2012-08-08 |
Sponsor Name:St George's University of London | ||
Full Title: Pain management in osteoarthritis using the centrally acting analgesics duloxetine and pregabalin | ||
Medical condition: Hand osteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-005402-11 | Sponsor Protocol Number: GLIDE | Start Date*: 2016-07-08 | |||||||||||
Sponsor Name:Guys and St Thomas NHS Foundation Trust | |||||||||||||
Full Title: The Impact of the Combination of the GLP-1 Analogue Liraglutide (Victoza®) and Laparoscopic Adjustable Gastric Banding (LAGB) on Diabetes Control | |||||||||||||
Medical condition: Type 2 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000003-16 | Sponsor Protocol Number: UPBEAT-TIF | Start Date*: 2018-11-06 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Prevention of Gestational Diabetes in Obese Pregnant Women; a Proof of Principle Study Targeting Early Pregnancy Intervention to Women at Risk | |||||||||||||
Medical condition: Gestational diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002094-22 | Sponsor Protocol Number: 2013MM002B | Start Date*: 2013-08-29 | |||||||||||
Sponsor Name:Royal Brompton and Harefield NHS Foundation Trust (RB&HFT) | |||||||||||||
Full Title: Comparison of ultra-low-dose Oral versus Transdermal Hormone Therapy on coagulation activation and metabolic risk factors for Cardiovascular Disease | |||||||||||||
Medical condition: The effect of oestrogen replacement therapy taken either orally or transdermally and observing any likely benefit of both these therapies on the risks Venous thromobembolic events and cardiovascul... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001877-34 | Sponsor Protocol Number: HOT-Treated | Start Date*: 2016-11-25 | |||||||||||||||||||||
Sponsor Name:South London and Maudsley NHS Foundation Trust [...] | |||||||||||||||||||||||
Full Title: Improving understanding of Heroin Overdose Testing: diamorphine dose-escalation testing in a treated population | |||||||||||||||||||||||
Medical condition: Opioid Overdose | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003557-15 | Sponsor Protocol Number: HMB-ICU | Start Date*: 2018-08-31 | |||||||||||
Sponsor Name:Guy's and St Thomas NHS Foundation Trust | |||||||||||||
Full Title: A Study to Investigate the Effect of β-Hydroxy-β-Methylbutyrate (HMB) on Skeletal Muscle Wasting in Early Critical Illness. | |||||||||||||
Medical condition: Critical illness | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001777-71 | Sponsor Protocol Number: RAVEN | Start Date*: 2020-05-06 | ||||||||||||||||
Sponsor Name:Guy’s and St Thomas' NHS Foundation Trust | ||||||||||||||||||
Full Title: Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patiENts - RAVEN | ||||||||||||||||||
Medical condition: Severe COVID-19 infection with risk of need for mechanical ventilation. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000177-37 | Sponsor Protocol Number: LITE | Start Date*: 2017-09-21 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Low-dose IL-2 to expand endogenous regulatory T cells and achieve tolerance in liver transplantation | |||||||||||||
Medical condition: Discontinuation of immunosuppression in liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
